福泰製藥 VRTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 453.36 | 90.38 | 31.30 | 4.64 | 1,205,900 | 1,191 |
| 2025Q3 | 391.64 | 91.10 | 27.60 | 4.20 | 1,186,200 | 1,083 |
| 2025Q2 | 445.20 | 89.46 | 3.99 | 1,151,100 | 1,033 | |
| 2025Q1 | 484.82 | 85.91 | 2.49 | 630,100 | 646 | |
| 2024Q4 | 402.70 | 90.06 | 3.53 | 1,026,000 | 913 | |
| 2024Q3 | 465.08 | 90.64 | 4.05 | 1,116,300 | 1,045 | |
| 2024Q2 | 468.72 | 103.95 | 30.09 | -13.87 | -3,514,700 | -3,594 |
| 2024Q1 | 418.01 | 88.37 | 29.83 | 4.21 | 1,139,500 | 1,100 |
| 2023Q4 | 406.89 | 85.35 | 30.22 | 3.71 | 988,500 | 969 |
| 2023Q3 | 347.74 | 87.23 | 26.67 | 3.97 | 1,038,100 | 1,035 |
| 2023Q2 | 351.91 | 87.52 | 27.80 | 3.52 | 1,026,400 | 916 |
| 2023Q1 | 315.07 | 86.28 | 24.38 | 2.69 | 779,000 | 700 |
| 2022Q4 | 288.78 | 94.96 | 22.65 | 3.14 | 1,033,500 | 819 |
| 2022Q3 | 289.54 | 94.67 | 23.24 | 3.59 | 1,126,700 | 931 |
| 2022Q2 | 281.79 | 106.48 | 29.40 | 3.13 | 1,106,300 | 811 |
| 2022Q1 | 260.97 | 107.34 | 28.37 | 2.96 | 1,040,900 | 762 |
| 2021Q4 | 219.60 | 99.06 | 2.98 | 877,700 | 770 | |
| 2021Q3 | 181.39 | 96.04 | 3.28 | 1,054,512 | 852 | |
| 2021Q2 | 201.63 | 132.00 | 0.26 | -37,935 | 67 | |
| 2021Q1 | 214.89 | 106.12 | 2.49 | 887,826 | 653 |